Dose-finding quantitative 18F-FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecological malignancies (Journal of Nuclear Medicine, 2015)

(untitled) - Gungor, H; Saleem, A; Babar, S; Dina, R; El-Bahrawy, M; Curry, E; Rama, N; Chen, M; Pickford, E; Agarwal, R; Blagden, S; Carme, S; et al.